Project Inform
   

Strategies for HIV therapy

April 2008    View PDF    En español

Federal recommendations for
first line HIV therapy

 

CLASS

 

PREFERRED

 

ALTERNATIVE

 

NOT RECOMMENDED

 

NRTIs

 

Truvada
Epzicom

 

Combivir
ddI + 3TC or FTC

 

d4T

 

NNRTI

 

Sustiva

 

Viramune

 

Rescriptor
Intelence

 

Protease
Inhibitor

 

Reyataz—boosted
Lexiva—boosted (2x/day)
Kaletra (2x/day)

 

Reyataz—unboosted
Lexiva—unboosted
Lexiva—boosted, 1x/day
Kaletra (1x/day)
Invirase—boosted

 

Invirase—unboosted
Viracept
Aptivus
Prezista

OTHER LINKS

Federal Guidelines

 
     
 

© 2008 Project Inform  1375 Mission Street,  San Francisco, CA 94103  415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST